拜尔斯道夫剑指KT-939:开拓药业股价承压、新药临考

21世纪经济报道
Mar 23

近期,开拓药业与拜尔斯道夫(Beiersdorf)围绕KT-939和提安明多®630展开多轮隔空喊话,商业纠纷从暗流涌动走向公开交锋。  梳理事件时间线,3月12日以来,开拓药业密集公布三项与化妆品原料KT-939相关的合作协议,加速推进该原料的商业化布局。  3月18日晚间,拜尔斯道夫突发公告,称为维护旗下提安明多®630创新成果与公平竞争环境,对开拓药业围绕KT-939的对外宣传与市场活动关注...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10